We hypothesized that the low expression of MARCH8 in lung cancer could be due to the regulation of aberrant transcription factors or epigenetic regulation, which may also be a key factor in the role of MARCH8 in human lung cancer. This evidence concerns the gene MARCHF8 and lung carcinoma.